The CDC's Morbidity and Mortality Weekly Report ( MMWR) resumed publishing after an unprecedented 2-week hiatus, but without the three H5N1 avian influenza papers that were slated to publish on Jan.
The progression of the species-jumping disease has been unprecedented, including the first-ever U.S. cases of infections in ...
A recent study conducted on human A(H5N1) cases in the United States found that conjunctivitis was the primary symptom ...
Get the latest on crucial health initiatives, research breakthroughs, and policy changes impacting public health and ...
DALLAS - Mangoceuticals, Inc. (NASDAQ: MGRX), a telemedicine company focused on men's wellness products with a market capitalization of $8.12 million, has announced progress in its H1N1 efficacy study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results